跳至主要内容
临床试验/NCT01643954
NCT01643954进行中(未招募)不适用

Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at Ohio State University/The James.

Ohio State University Comprehensive Cancer Center2 个研究点 分布在 1 个国家目标入组 1,531 人开始时间: 2008年9月23日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
1,531
试验地点
2
主要终点
Collect and analyze descriptive characteristics of patient population and summarize patient outcome data.

研究概览

简要总结

This is a retrospective/prospective Analysis of surgical outcomes of robotic prostatectomy.

详细描述

This retrospective / prospective study will allow us to collect and analyze the presurgical, peri-operative, and outcome data of patients who undergo robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center, beginning February 2008 onwards.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Patients with prostate cancer who have undergone robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center.
  • Ability to understand and willingness to sign the written informed consent document.
  • 18 years and older
  • Inclusion Criteria:
  • Patients with prostate cancer that will undergo robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center.
  • Ability to understand and willingness to sign the written informed consent document.
  • 18 years and older

排除标准

  • 未提供

结局指标

主要结局

Collect and analyze descriptive characteristics of patient population and summarize patient outcome data.

时间窗: up to 20 years

次要结局

  • Determine the overall survival(up to 20 years)
  • Correlate the patient characteristics to the surgical outcomes.(up to 20 years)
  • Determine the rate of local recurrence in patients undergoing robotic prostatectomy and compare these metrics to historical controls.(up to 20 years)
  • disease- free survival(up to 20 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Steven Clinton

Principal Investigator

Ohio State University Comprehensive Cancer Center

研究点 (2)

Loading locations...

相似试验